Among patients diagnosed with hypertension, the use of ACE inhibitors (ACEi) was highest in W1 (type 1 diabetes, 65.0%; type 2 diabetes, 55.7%) but had fallen by W7 (type 1 diabetes, 55.9%; type 2 diabetes, 41.1%). Here, ACE is linked to hypertensive disorder.